Rescue experiments showed that inhibition of Sod1 counteracted the therapeutic effects of Exo/ASO-TNF or Exo/2DG on experimental NASH in mice (Fig. 8). Here, SOD1 is linked to metabolic dysfunction-associated steatohepatitis.